Methods of Determining Irritable Bowel Syndrome and Efficiency of Probiotics in Treatment: A Review

Sisson, 2014, Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12-week double-blind study, Aliment. Pharmacol. Ther, 40, 51, 10.1111/apt.12787 Quigley, 2012, A Global Perspective on Irritable Bowel Syndrome: A Consensus Statement of the World Gastroenterology Organisation Summit Task Force on Irritable Bowel Syndrome, J. Clin. Gastroenterol, 46, 356, 10.1097/MCG.0b013e318247157c Zhu, 2022, Determine independent gut microbiota-diseases association by eliminating the effects of human lifestyle factors, BMC Microbiol, 22, 4, 10.1186/s12866-021-02414-9 Ceccherini, 2022, Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis, Nutrients, 14, 2689, 10.3390/nu14132689 Yoon, 2015, Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial, J. Clin. Biochem. Nutr, 57, 129, 10.3164/jcbn.15-14 Barandouzi, 2022, Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome, Sci. Rep, 12, 1648, 10.1038/s41598-022-05756-0 Zhang, 2022, Telomere is shortened in patients with irritable bowel syndrome in the Chinese population, J. Gastroenterol. Hepatol, 37, 1749, 10.1111/jgh.15912 Ait Abdellah, 2023, Effect of a Multi-strain Probiotic on Leaky Gut in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study, Dig. Dis, 41, 489, 10.1159/000526712 Choi, 2011, A Randomized, Double-blind, Placebo-controlled Multicenter Trial of Saccharomyces boulardii in Irritable Bowel Syndrome: Effect on Quality of Life, J. Clin. Gastroenterol, 45, 679, 10.1097/MCG.0b013e318204593e Czerucka, 2007, Review article: yeast as probiotics -Saccharomyces boulardii: REVIEW: SACCHAROMYCES BOULARDII AS A PROBIOTIC, Aliment. Pharmacol. Ther, 26, 767, 10.1111/j.1365-2036.2007.03442.x Kesuma, 2019, Blastocystis ST-1 is associated with Irritable Bowel Syndrome-diarrhoea (IBS-D) in Indonesian adolescences, Parasite Epidemiol. Control, 6, e00112, 10.1016/j.parepi.2019.e00112 Mazzawi, 2022, Gut Microbiota Manipulation in Irritable Bowel Syndrome, Microorganisms, 10, 1332, 10.3390/microorganisms10071332 McFarland, 2010, Systematic review and meta-analysis of Saccharomyces boulardii in adult patients, World J. Gastroenterol, 16, 2202, 10.3748/wjg.v16.i18.2202 Hod, 2017, A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS, Neurogastroenterol. Motil, 29, e13037, 10.1111/nmo.13037 Manning, 2020, Therapy of IBS: Is a Low FODMAP Diet the Answer?, Front. Psychiatry, 11, 865, 10.3389/fpsyt.2020.00865 Rossi, 2018, Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome, Clin. Gastroenterol. Hepatol, 16, 385, 10.1016/j.cgh.2017.09.055 Maccaferri, 2012, IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation, Gut Microbes, 3, 406, 10.4161/gmic.21009 Ahmed, 2020, Irritable Bowel Syndrome : Clinical Review, World Fam. Med. JournalMiddle East J. Fam. Med, 18, 106, 10.5742/MEWFM.2020.93863 Kanazawa, 2005, Development of irritable bowel syndrome may be associated with a parental history of bowel problems, Aliment. Pharmacol. Ther, 22, 166, 10.1111/j.1365-2036.2005.02518.x Tack, 2012, Functional Diarrhea, Gastroenterol. Clin. North Am, 41, 629, 10.1016/j.gtc.2012.06.007 Carrasco-Labra, 2019, AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D), Gastroenterology, 157, 859, 10.1053/j.gastro.2019.06.014 Mezzasalma, 2016, A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multi-species Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation, BioMed Res. Int, 2016, 1, 10.1155/2016/4740907 Kindt, 2022, Belgian consensus on irritable bowel syndrome, Acta Gastro Enterol. Belg, 85, 360, 10.51821/85.2.10100 Savarino, 2022, Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility, United Eur. Gastroenterol. J, 10, 556, 10.1002/ueg2.12259 Parker, 2018, Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration, Nutrition, 45, 125, 10.1016/j.nut.2017.06.024 Grzesiak, 2017, Serotonin-Related Gene Variants in Patients with Irritable Bowel Syndrome and Depressive or Anxiety Disorders, Gastroenterol. Res. Pract, 2017, 1, 10.1155/2017/4290430 Yoon, 2014, Effect of multi-species probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial: Probiotics in irritable bowel syndrome, J. Gastroenterol. Hepatol, 29, 52, 10.1111/jgh.12322 Trinkley, 2014, Medication Management of Irritable Bowel Syndrome, Digestion, 89, 253, 10.1159/000362405 Chang, 2016, Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation, Aliment. Pharmacol. Ther, 44, 1114, 10.1111/apt.13807 Whelan, 2018, The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice, J. Hum. Nutr. Diet, 31, 239, 10.1111/jhn.12530 Thijssen, 2016, Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome, Eur. J. Gastroenterol. Hepatol, 28, 8, 10.1097/MEG.0000000000000484 Ducrotté, 2012, Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome, World J. Gastroenterol, 18, 4012, 10.3748/wjg.v18.i30.4012 Didari, 2015, Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis, World J. Gastroenterol, 21, 3072, 10.3748/wjg.v21.i10.3072 Liang, 2019, Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis, Medicine (Baltimore), 98, e16068, 10.1097/MD.0000000000016068 Szałwińska, 2020, IBS-Symptoms in IBD Patients—Manifestation of Concomitant or Different Entities, J. Clin. Med, 10, 31, 10.3390/jcm10010031 Bundeff, 2014, Selective Serotonin Reuptake Inhibitors for the Treatment of Irritable Bowel Syndrome, Ann. Pharmacother, 48, 777, 10.1177/1060028014528151 Preston, 2018, Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study, Benef. Microbes, 9, 697, 10.3920/BM2017.0105 Sun, 2018, The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial, Sci. Rep, 8, 2964, 10.1038/s41598-018-21241-z Schumann, 2018, Randomised clinical trial: yoga vs a low-FODMAP diet in patients with irritable bowel syndrome, Aliment. Pharmacol. Ther, 47, 203, 10.1111/apt.14400 Lajis, 2012, Depigmenting Effect of Kojic Acid Esters in Hyperpigmented B16F1 Melanoma Cells, J. Biomed. Biotechnol, 2012, 1, 10.1155/2012/952452 Chong, 2019, The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy, Front. Microbiol, 10, 1136, 10.3389/fmicb.2019.01136 Holvoet, 2021, Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial, Gastroenterology, 160, 145, 10.1053/j.gastro.2020.07.013 Whorwell, 2006, Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome, Am. J. Gastroenterol, 101, 1581, 10.1111/j.1572-0241.2006.00734.x Chey, 2011, Efficacy and Safety of Once-Daily Linaclotide Administered Orally for 26 Weeks in Patients With IBS-C: Results From a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial, Gastroenterology, 140, 10.1016/S0016-5085(11)60550-7 Dapoigny, 2012, Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: A randomized, double-blind study, World J. Gastroenterol, 18, 2067, 10.3748/wjg.v18.i17.2067 Polisena, 2013, Case studies that illustrate disinvestment and resource allocation decision-making processes in health care: A systematic review, Int. J. Technol. Assess. Health Care, 29, 174, 10.1017/S0266462313000068 Thijssen, 2016, Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome:, Eur. J. Gastroenterol. Hepatol, 28, 8, 10.1097/MEG.0000000000000484 Major, 2014, irritable bowel syndrome, inflammatory bowel disease and the microbiome, Curr. Opin. Endocrinol. Diabetes Obes, 21, 15, 10.1097/MED.0000000000000032 Gatto, 2021, Driving Green Investments by Measuring Innovation Impacts. Multi-Criteria Decision Analysis for Regional Bioeconomy Growth, Sustainability, 13, 11709, 10.3390/su132111709